Position in ORKA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$40,817,553
+$26,149,447 QoQ
Shares Held
428,891
+43.4% QoQ
Ownership
0.648%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#35
of 254 holders
Holding Since
Dec 2020
21 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in ORKA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,813,537,836 across 424 Biotechnology names. ORKA ranks #41 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in ORKA
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $40,817,553 | 428,891 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $14,668,106 | 299,044 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $8,514,197 | 280,904 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $4,225,002 | 219,709 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $2,490,614 | 222,178 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $611,342 | 59,585 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,241,813 | 64,044 | Shares | Defined | 2025-02-14 | |
| 2024-03-31 ABIO | — | 20,982 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 ABIO | — | 20,982 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 ABIO | — | 20,982 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 ABIO | — | 20,982 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 ABIO | — | 20,982 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 ABIO | — | 17,517 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 ABIO | — | 17,517 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 ABIO | — | 17,517 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 ABIO | — | 17,517 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 ABIO | — | 17,517 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 ABIO | — | 17,517 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 ABIO | — | 17,517 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 ABIO | — | 17,517 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 ABIO | — | 17,525 | Shares | Defined | 2021-02-11 | |
| No filing history on record for this holder in this stock. | ||||||